Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen and nitrogen species (ROS/RNS) are a diverse group of highly reactive molecules, including superoxide, hydrogen peroxide, and peroxynitrite, that are generated as natural byproducts of cellular metabolism and immune activity (Sies & Jones, 2020, Nature Reviews Molecular Cell Biology). While they function as essential secondary messengers in physiological signaling pathways, an imbalance between their production and the capacity of antioxidant systems leads to oxidative and nitrosative stress. This stress results in the modification of redox-sensitive cellular components, such as the oxidation of cysteine thiols in proteins, lipid peroxidation, and oxidative DNA damage (Di Meo et al., 2016, Oxidative Medicine and Cellular Longevity). Such damage is implicated in the pathogenesis of various conditions, including neurodegenerative diseases, cardiovascular disorders, and chronic inflammation. Therapeutic interventions, such as the use of N-acetylcysteine or Edaravone, aim to neutralize these reactive species or enhance endogenous antioxidant defenses to mitigate cellular injury (Abe et al., 2014, Expert Opinion on Pharmacotherapy). However, targeting these species is challenging due to their dual role in both essential signaling and pathological damage, often leading to poor clinical outcomes for non-specific antioxidant therapies.
Direct chemical neutralization of free radicals, donation of electrons to reactive species, and induction of endogenous antioxidant enzymes via pathways such as Nrf2-ARE (PMID: 25672622, PMID: 28249519).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen and nitrogen species and redox-sensitive cellular components (ROS/RNS).